Pharma Giants: Roche and Novartis

How Basel became a pharmaceutical hub, home to Roche and Novartis, why pharma is Switzerland's largest export, and its reliance on the US market.

Pharmaceuticals are Switzerland’s largest export.

Basel

Basel grew from a 19th-century dye industry into a pharma hub.
Roche (founded 1896) and Novartis (formed from the merger of Ciba-Geigy and Sandoz in 1996) are headquartered there.

Why Basel

Chemistry tradition.
Universities and research.
Location near Germany and France.
Skilled workers and low taxes.

Exports

Pharma and chemicals make up a large share of Swiss exports, especially to the US.

Research

Swiss pharma firms spend heavily on R&D, developing cancer drugs and other treatments.

Tariff risk

In 2025, the US threatened high tariffs on Swiss goods and pharma, highlighting dependence on the US market.

India link

Novartis fought a landmark patent case in India, losing at the Supreme Court in 2013 over its cancer drug Glivec, a key case on patent standards.

The Glivec case

India's Supreme Court refused Novartis a patent on a modified cancer drug in 2013, allowing cheaper generics in India.

Thinking Swiss exports are mainly watches and chocolate

Pharmaceuticals are the largest export.

Key takeaways

Pharmaceuticals are Switzerland's largest export.
Basel hosts Roche and Novartis.
Chemistry tradition and research built the cluster.
Novartis lost the Glivec patent case in India in 2013.